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Background/Introduction
Immune and inflammatory mechanisms are considered
to play a key role in the pathogenesis of atherosclerosis.
Toll-like-Receptor4 and CD14 receptors are involved in
the intracellular signalling pathway of the innate
immune and inflammatory responses against pathogens.
Functional polymorphisms of TLR4 and CD14 have so
far conflicting impact on coronary artery disease.
Aims/Objectives
We study the most frequent functional polymorphisms
of TLR4 -Asp299Gly, Thr399Ile- and of the promoter of
CD14 (T/C-159) aiming to identify if they predispose to
coronary artery disease.
Method
We included two study groups. The study group 1 was
consisted of 100 human subjects whose post mortem
autopsy revealed severe atheromatosis of their coronary
arteries. 100 patients who underwent cardiac Multi-
Detector-row-Computed-Tomography (MDCT) and
they were found positive for severe coronary atheroma-
tosis were included in the study group 2. Our case
group consists of both group 1 and 2. The control
group consists of 100 healthy individuals. DNA was
obtained from 100 paraffin embedded human aortic tis-
sues and 100 blood samples for our study groups
respectively. DNA from the control group was also
obtained from blood samples. Genotyping was per-
formed by allele specific PCR or PCR-RFLP analysis.
Results
There was no statistical difference between case group
and control group with regards to the frequencies of
299Gly and 399Ile allele of TLR4. Frequencies of T
allele of the CD14 promoter, regarding the of CD14(T/
C-159) functional polymorphism, are significantly higher
in the control group compared to the case group (37%
vs 23.75%), p = 0.05.
Discussion/Conclusion
The results of this study suggest that functional poly-
morphisms of TLR4 do not have an impact on coronary
atheromatosis for the population we studied. However,
polymorphisms of CD14 seem to have a protective role
against coronary artery disease. Our next step would be
to include more patients in our study and find an easily
quantified expression of CD14 that could correlate with
coronary atheromatosis.
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